logo_fibro-targetsThe Medizinische Hochschule Hannover & Greenpharma have filed a new patent application concerning anti-fibrotic natural compounds within FIBROTARGETS. The invention relates to miRNA modulators including several natural compounds for anti-fibrotic therapies. Further, the invention encompasses a kit comprising said inhibitor of the particular miRNA. The present invention also relates to an in vitro method for identifying a compound for preventing or treating fibrosis.

This work was supported by the European Commission FP7 Programme [FIBROTARGETS project grant HEALTH-2013-6029047].

Greenpharma S.A.S 3, allée du Titane - 45100 Orléans, France
Legal - mikii.fr/ web agency creation site internet orleans